ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 180 filers reported holding ABCELLERA BIOLOGICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,815,000 | -42.4% | 394,602 | -19.1% | 0.00% | -100.0% |
| Q2 2023 | $3,151,000 | -63.7% | 487,845 | -57.6% | 0.00% | -50.0% |
| Q1 2023 | $8,681,000 | -23.1% | 1,151,261 | +3.3% | 0.00% | -33.3% |
| Q4 2022 | $11,289,000 | +4.9% | 1,114,514 | +2.4% | 0.00% | 0.0% |
| Q3 2022 | $10,766,000 | +33.4% | 1,088,473 | +43.7% | 0.00% | +50.0% |
| Q2 2022 | $8,068,000 | +0.0% | 757,603 | -8.4% | 0.00% | 0.0% |
| Q1 2022 | $8,066,000 | -33.2% | 827,293 | -2.0% | 0.00% | -33.3% |
| Q4 2021 | $12,074,000 | +223.1% | 844,362 | +352.7% | 0.00% | +200.0% |
| Q3 2021 | $3,737,000 | +10.6% | 186,500 | +21.4% | 0.00% | 0.0% |
| Q2 2021 | $3,379,000 | +49.0% | 153,577 | +129.9% | 0.00% | 0.0% |
| Q1 2021 | $2,268,000 | +1743.9% | 66,792 | +2074.9% | 0.00% | – |
| Q4 2020 | $123,000 | – | 3,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |